Share this
Oculis and European Biotech Acquisition Corp. Announce Business Combination Agreement
October 25, 2022
Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche
Poseida to receive $110 million upfront, with overall potential deal value of up to $6 billion • August 5, 2022
Chambers USA 2022 Recognizes Cooley Lawyers + Practices
June 2, 2022
Chambers USA 2021 Recognizes Cooley Lawyers + Practices
May 28, 2021
Cooley Advises on Follow-On Offerings for Reata + argenx
Transactions total more than $1 billion • December 5, 2019
Best Lawyers 2020 – Cooley
November 18, 2019
ERYTECH – $144 Million IPO
November 22, 2017
Inotek Pharmaceuticals – $50 Million Follow-On
August 18, 2016
Selecta Biosciences – $74 Million IPO
July 25, 2016
Cooley Elects 12 New Partners
December 1, 2015
Voyager Therapeutics – IPO
November 19, 2015
Inotek Pharmaceuticals – $40 Million IPO
February 23, 2015
Cooley Expands National IP Practice, Adds Leading Life Sciences Patent Group – Media
Bloomberg News, The American Lawyer, Boston Business Journal, Law360, etc. • April 2, 2014